Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.11 USD | +0.33% | +10.09% | -51.31% |
May. 24 | Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating | MT |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
Financials (USD)
Sales 2024 * | 6.17B | Sales 2025 * | 7.59B | Capitalization | 2.5B |
---|---|---|---|---|---|
Net income 2024 * | -141M | Net income 2025 * | -65M | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | 187M | Net cash position 2025 * | 205M | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
-17.7
x | P/E ratio 2025 * |
-40
x | Employees | 1,117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.11% |
Latest transcript on agilon health, inc.
1 day | +0.33% | ||
1 week | +10.09% | ||
Current month | +11.09% | ||
1 month | +22.20% | ||
3 months | -3.93% | ||
6 months | -46.07% | ||
Current year | -51.31% |
Managers | Title | Age | Since |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 15-12-31 |
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Ronald Williams
FOU | Founder | 74 | 15-12-31 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 8 M€ | +4.90% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 6.11 | +0.33% | 3,741,767 |
24-05-24 | 6.09 | +7.79% | 3,675,929 |
24-05-23 | 5.65 | -5.68% | 3,737,976 |
24-05-22 | 5.99 | +7.93% | 4,912,235 |
24-05-21 | 5.55 | +3.54% | 2,248,926 |
Delayed Quote Nyse, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.31% | 2.5B | |
-25.62% | 2.78B | |
-1.15% | 218M | |
-41.92% | 202M | |
-42.98% | 189M | |
-33.52% | 114M |
- Stock Market
- Equities
- AGL Stock